Caixin
Apr 19, 2022 08:00 AM

Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd.’s Net Profit Rose 377.9% in First Quarter of 2022

Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (北京万泰生物药业股份有限公司) (603392.SH) reported a net profit of 1.4 billion yuan in the first quarter of 2022, up 377.9% year-on-year.

Meanwhile, the company posted 3.2 billion yuan in revenue, up 284.8% year-on-year.

At the end of the reporting period, it had 9.1 billion yuan in total assets and 3.2 billion yuan in total liabilities, with a liability-to-asset ratio of 34.8%.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST